Relapsing Malaria: A Case Report of Primaquine Resistance

Primaquine (an 8-aminoquinoline malarial therapy) is the only FDA-approved therapy to treat the hypnozoite stage of P. vivax. We think of relapse occurring because of parasitic resistance or poor compliance secondary to drug toxicities. However, in patients with repeated treatment failure, we must c...

Descripción completa

Detalles Bibliográficos
Autores principales: Dijanic, Christopher, Nickerson, Jillian, Shakya, Sunita, Dijanic, Amanda, Fabbri, Marilyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866905/
https://www.ncbi.nlm.nih.gov/pubmed/29713556
http://dx.doi.org/10.1155/2018/9720823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866905/
https://www.ncbi.nlm.nih.gov/pubmed/29713556
http://dx.doi.org/10.1155/2018/9720823

Ejemplares similares